175 related articles for article (PubMed ID: 29407301)
1. Improvement of Blood Pressure Control in Renal Transplant Recipients-Retrospective Longitudinal Study.
Adrych D; Kuźmiuk-Glembin I; Tylicki L; Heleniak Z; Garnier H; Wiśniewski J; Rutkowski P; Rutkowski B; Dębska-Ślizień A
Transplant Proc; 2018; 50(1):155-159. PubMed ID: 29407301
[TBL] [Abstract][Full Text] [Related]
2. Hypertension, antihypertensive agents and outcomes following renal transplantation.
Tutone VK; Mark PB; Stewart GA; Tan CC; Rodger RS; Geddes CC; Jardine AG
Clin Transplant; 2005 Apr; 19(2):181-92. PubMed ID: 15740553
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Hypertension in Renal Transplant Recipients in Four Independent Cross-Sectional Analyses.
Kuźmiuk-Glembin I; Adrych D; Tylicki L; Heleniak Z; Garnier H; Wiśniewski J; Rutkowski P; Rutkowski B; Dębska-Ślizień A
Kidney Blood Press Res; 2018; 43(1):45-54. PubMed ID: 29402869
[TBL] [Abstract][Full Text] [Related]
4. Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.
Małyszko J; Małyszko J; Bachórzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
Transplant Proc; 2009 Oct; 41(8):3069-72. PubMed ID: 19857679
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure control in kidney transplantation: therapeutic implications.
Premasathian NC; Muehrer R; Brazy PC; Pirsch JD; Becker BN
J Hum Hypertens; 2004 Dec; 18(12):871-7. PubMed ID: 15318162
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of arterial hypertension and the number and classes of antihypertensive drugs prescribed for patients late after kidney transplantation.
Kurnatowska I; Królikowski J; Jesionowska K; Marczak A; Krajewska J; Zbróg Z; Nowicki M
Ann Transplant; 2012; 17(1):50-7. PubMed ID: 22466909
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
[TBL] [Abstract][Full Text] [Related]
8. Influence of Renin-Angiotensin System Blockers on Graft Function in Retrospective Analysis of Pairs of Renal Transplant Recipients From the Same Donor.
Zakrzewska A; Tylicki L; Debska-Slizien A
Transplant Proc; 2018; 50(6):1838-1841. PubMed ID: 30056911
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study.
Andrés A; Morales E; Morales JM; Bosch I; Campo C; Ruilope LM;
Transplant Proc; 2006 Oct; 38(8):2419-23. PubMed ID: 17097955
[TBL] [Abstract][Full Text] [Related]
10. Hypertension in kidney transplant recipients.
Ponticelli C; Cucchiari D; Graziani G
Transpl Int; 2011 Jun; 24(6):523-33. PubMed ID: 21382101
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.
Stigant CE; Cohen J; Vivera M; Zaltzman JS
Am J Kidney Dis; 2000 Jan; 35(1):58-63. PubMed ID: 10620545
[TBL] [Abstract][Full Text] [Related]
12. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.
Karunaratne K; Stevens P; Irving J; Hobbs H; Kilbride H; Kingston R; Farmer C
Nephrol Dial Transplant; 2013 Aug; 28(8):2107-16. PubMed ID: 23658247
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation.
Holgado R; Anaya F; Del Castillo D
Nephrol Dial Transplant; 2001; 16 Suppl 1():117-20. PubMed ID: 11369838
[TBL] [Abstract][Full Text] [Related]
14. Association of the optic disc structure with the use of antihypertensive medications: the thessaloniki eye study.
Harris A; Topouzis F; Wilson MR; Founti P; Kheradiya NS; Anastasopoulos E; Gong G; Yu F; Jonescu-Cuypers CP; Pappas T; Koskosas A; Coleman AL
J Glaucoma; 2013 Sep; 22(7):526-31. PubMed ID: 22411020
[TBL] [Abstract][Full Text] [Related]
15. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the early period after kidney transplantation.
Orlić L; Mikolasević I; Sladoje-Martinović B; Bubić I; Pavletić-Persić M; Racki S
Coll Antropol; 2013 Sep; 37(3):809-14. PubMed ID: 24308221
[TBL] [Abstract][Full Text] [Related]
16. Hypertension following kidney transplantation.
Rubin MF
Adv Chronic Kidney Dis; 2011 Jan; 18(1):17-22. PubMed ID: 21224026
[TBL] [Abstract][Full Text] [Related]
17. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E
Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients.
Kim W; Lee S; Kang SK; Yu HC; Cho BH; Park SK
Transplant Proc; 2002 Dec; 34(8):3223-4. PubMed ID: 12493427
[No Abstract] [Full Text] [Related]
19. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
